Navigation Links
FDA Warns VaxGen On Anthrax Vaccine

The Food and Drug Administration has warned the manufacturers of a new vaccine for anthrax for making false claims about the purity and effectiveness// of the vaccine. VaxGen Inc was accused of inflating the claims based on a few studies, the data for which is not enough for issuing such statements.

The FDA took umbrage to a promotional handed out by the company in October, which claimed that the vaccine could be made "at nearly 100% purity." The promotional also claimed that the vaccine gives a longer immunity as s compared to some older vaccines. The FDA declared that such claims could not be made on the basis of only a handful of studies. The regulator also threatened legal action against the company unless it stops "disseminate truthful, non-misleading, and complete information" about the vaccine. Paul Laland, a VaxGen spokesman, said, "Based on our internal assessment and research of industry standards, we did not believe this was material information. We'll review it internally, and we're going to respond, and if needed we'll put a plan together. If there is something that's incorrect, then we will take corrective action." The company has been struggling to make 75 million doses of anthrax vaccine under federal contracts. These doses are believed to be enough to immunize 25 million people.
'"/>




Page: 1

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
3. ADB Report Warns of Bird-Flu Catastrophe
4. FDA Warns Against Birth-Control Patch
5. Charlotte Church Warns kiss n tell girls not to flirt with Henson
6. UK Committee Warns on Food Shortages Due to Flu Epidemic
7. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
8. Bishop Warns Against Change in Mercy Killing Laws
9. Manitoba Ombudsman Warns Pharmacists
10. Doctors In New Zealand Warns Against Using Ayurveda Medicines
11. Oxford Radcliffe Hospitals Warns Of Further Job Losses
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: